SAN FRANCISCO, Dec. 5, 2025 /PRNewswire/ -- Nektar Therapeutics (NASDAQ: NKTR) today announced that the Organization and Compensation Committee of Nektar's Board of Directors granted non-qualified stock options to purchase an aggregate of 18,310 shares of its common stock to two...
Hence then, the article about nektar therapeutics reports inducement grants under nasdaq listing rule 5635 c 4 was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Nektar Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) )
Also on site :
- Prosecutors release new video showing moments before shooting at press dinner
- Thousands of Illinois residents could lose SNAP benefits beginning Friday
- Pomerantz Law Firm Announces the Filing of a Class Action Against Regencell Bioscience Holdings Limited and Certain Officers - RGC